So, play for eight hours, have to get off and let it charge for a while and then ... with unmet medical needs today and unlock human potential tomorrow." Neuralink was granted FDA approval for a human ...
The nasal spray product delivers 10mg of naloxone hydrochloride in a single dose. The Food and Drug Administration (FDA) has approved Rezenopy (naloxone hydrochloride) nasal spray for the emergency ...
Roche Holding's Alecensa lung-cancer drug received a new approval from the U.S. Food and Drug Administration as an additional treatment for patients who have undergone surgery to remove their tumor.
Roche Holding's Alecensa lung-cancer drug received a new approval from the U.S. Food and Drug Administration as an additional treatment for patients who have undergone surgery to remove their tumor.
Taking weight loss drugs is no longer the road less traveled, and people are going over 1,000 miles to get their hands on ...
Neurovalens Ltd recently received U.S. FDA clearance for its Modius Stress device, a neurostimulator that treats people ...
The South San Francisco, Calif.-based company said that the U.S. Food and Drug Administration had approved Alecensa in treating patients with anaplastic lymphoma kinase-positive non-small cell ...
(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced on Wednesday that it has received FDA approval for its Over the Counter Naloxone Hydrochloride or HCI Nasal Spray, USP, 4mg. This nasal spray ...
The South San Francisco, Calif.-based company said that the U.S. Food and Drug Administration had approved Alecensa in treating patients with anaplastic lymphoma kinase-positive non-small cell ...
(RTTNews) - Roche (RHHBY) announced the FDA has approved Alecensa for adjuvant treatment ... Sign up for our newsletter to get the latest on the transformative forces shaping the global economy ...
The US FDA approval of Zeffdiffra and the global strategic partnerships between innovators are driving the development of drugs for MASH (1 Trusted Source MASH was earlier referred to as ...
Roche announced today that the US Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment following tumour resection for patients with anaplastic lymphoma kinase ...